Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

605 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insight and gender in schizophrenia and other psychoses.
Cobo J, Nieto L, Ochoa S, Pousa E, Usall J, Baños I, González B, Ruiz I; Insight Barcelona Research Group; Ruiz AI. Cobo J, et al. Psychiatry Res. 2016 Sep 30;243:268-77. doi: 10.1016/j.psychres.2016.04.089. Epub 2016 Jun 16. Psychiatry Res. 2016. PMID: 27423634
Psychosis and gender.
Ochoa S, Usall J, Cobo J, Labad J, Kulkarni J. Ochoa S, et al. Among authors: cobo j. Schizophr Res Treatment. 2012;2012:694870. doi: 10.1155/2012/694870. Epub 2012 Apr 18. Schizophr Res Treatment. 2012. PMID: 22966442 Free PMC article. No abstract available.
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Usall J, Huerta-Ramos E, Labad J, Cobo J, Núñez C, Creus M, Parés GG, Cuadras D, Franco J, Miquel E, Reyes JC, Roca M; RALOPSYCAT Group. Usall J, et al. Among authors: cobo j. Schizophr Bull. 2016 Mar;42(2):309-17. doi: 10.1093/schbul/sbv149. Epub 2015 Nov 20. Schizophr Bull. 2016. PMID: 26591005 Free PMC article. Clinical Trial.
Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.
Labad J, Martorell L, Huerta-Ramos E, Cobo J, Vilella E, Rubio-Abadal E, Garcia-Pares G, Creus M, Núñez C, Ortega L, Miquel E; RALOPSYCAT Group; Usall J. Labad J, et al. Among authors: cobo j. Eur Neuropsychopharmacol. 2016 Oct;26(10):1683-9. doi: 10.1016/j.euroneuro.2016.08.006. Epub 2016 Aug 18. Eur Neuropsychopharmacol. 2016. PMID: 27546373
A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors.
Pousa E, Ochoa S, Cobo J, Nieto L, Usall J, Gonzalez B, Garcia-Ribera C, Pérez Solà V, Ruiz AI; Insight Barcelona Research Group; Baños I, Cobo J, García-Ribera C, González B, Massons C, Nieto L, Monserrat C, Ochoa S, Pousa E, Ruiz AI, Ruiz I, Sanchez-Cabezudo D, Usall J. Pousa E, et al. Among authors: cobo j. Schizophr Res. 2017 Nov;189:61-68. doi: 10.1016/j.schres.2017.02.016. Epub 2017 Feb 22. Schizophr Res. 2017. PMID: 28237605
605 results